Pegylated interferon lambda (pegIFNλ)

BIOLOGICAL2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Hepatitis CHepatitis C Virus (HCV)

Phase 2

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

CompletedNCT01309932

Bristol-Myers SquibbHepatitis C

Start: 2011-03-31End: 2014-09-30Updated: 2015-10-09

Phase 3

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

CompletedNCT01616524

Bristol-Myers SquibbHepatitis C Virus (HCV)

Start: 2012-07-31End: 2014-09-30Updated: 2015-10-09